Immunity, preparedness required to deal with Covid 19: Dr Randeep Guleria

New Delhi: The Covid vaccines in use in India are providing cover for the original Wuhan strain but if the need for another booster dose is felt as new variants emerge, it should be able to provide protection against all circulating as well as future strains, according to former AIIMS director Dr Randeep Guleria.

What is the immunity status of Indians?

Dr Guleria stressed on the need for two data sets - first to ascertain whether the degree of immunity is waning and secondly if the vaccines need to be tweaked when asked if it is time for another precaution dose almost a year after the first one amid the recent uptick in Covid cases.

"Currently the vaccines that we have in India are covering what was originally the Wuhan strain. After that we had so many variants. And therefore if we have to have a new vaccine, it should provide cover for the circulating strains like we do for influenza," he said.

The renowned pulmonologist, who was part of the national Covid task force, highlighted the need for research on developing vaccines which will cover not only the current circulating strains but also from the emerging variants.

The emergence of XBB 1.16

India is once again seeing a rise in Covid cases and Prime Minister Narendra Modi held a high-level meeting on 22 March to review the Covid situation and also took stock of public health preparedness.

Terming the new XBB.1.16 variant as a "new kid on the block" that could be driving the recent rise, Dr Guleria said new variants will keep coming as the virus keeps on mutating over time but "as long as they don't lead to severe illness, hospitalisation and deaths, it is alright because it helps in giving some degree of immunity to the population if they have a mild illness".

Wait and watch the policy for XBB 1.16

On whether XBB 1.16 has the potential to drive a fresh wave of cases or lead to significant rise in cases in the next few days, he said, "Even if we see a surge, there is no need to worry, as long it does not translate into hospitalization and deaths."

Is Covid 19 now endemic?

Dr Gulleria said, "In my opinion, Covid has more or less become endemic. We have a good amount of immunity. Cases will continue and it's going to be here. We will continue to have some waves of cases coming and going but it is not going to cause the kind of waves we saw in the last two years. We will have to learn to live with it."

Rise in Influenza cases with H3N2

Influenza virus has been around for quite a long time.

"We had the H1N1 pandemic in 1918 also. Therefore this virus has been there but it keeps changing and the current circulating strain is H3N2," he said.

It behaves very similarly to flu-like syndrome and one gets fever, sore throat, body aches, and a runny nose along with a cough that can be persistent and troublesome.

And some people in the high risk group can also have pneumonia, which can be more serious and need hospital admissions, he said.

Everyone who comes in contact with an infected patient is at risk of getting influenza, he said.

"So we all will get influenza on and off but then there is a group which is at risk of getting severe infection and which may need hospitalisation and sometimes even cause death." Those who are elderly and have co-morbidities are prone to getting more severe infection, he said.

Recurrent viruses and lung damage

"But we have a small group of people who had Covid-19 which caused lung damage and they had lung fibrosis. So their lungs were already compromised to some extent and in some, their immunity is also low. So in this small group of people who had Covid and have residual effects of Covid, they again fall in the high risk category and can have a more severe infection," he said.

"One of the downsides or the collateral damage we saw in Covid was that a lot of patients suffering from other diseases such as cancer and tuberculosis suffered a lot as the focus was only on managing Covid-19." "We were not able to manage these illnesses amid the outbreak. Patients were not diagnosed at the right time. The treatment was not being provided on time. So we develop a strategy where we can manage the outbreak but at the same time our health systems, the policies and programmes continue and do not suffer," he said.

Active surveillance is a must

Besides, Dr Guleria stressed being prepared and deploying active surveillance. "So that if there is a surge in the number of cases, be it of influenza or Covid or any other new viral disease, we should be able to pick it up early and say that there is an outbreak that is happening," he said.

He also underlined the need for good laboratory networks so that samples can be tested in case of an outbreak and a surveillance system which is hospital and clinical-based. If there is a cluster of cases in a particular place, and a doctor or a healthcare worker notices a large of people coming with peculiar types of symptoms, he or she should immediately report that this may be an outbreak that is developing so that investigation can be done, it can be managed and prevented from spreading, Dr Guleria said.

For both Covid and influenza, Dr Guleria said the precautions in terms of Covid- appropriate behaviour will protect against all these viruses. "If you have a definite diagnosis, for influenza there is a definite antiviral drug that is available which we used a lot even during the H1N1 pandemic it is available as oseltamivir (Tamiflu) which is useful against the influenza virus. So that drug can be given to a high-risk group in case of a definite diagnosis besides symptomatic treatment," he elaborated.

"Finally if you are in the high-risk group then you have a vaccine which is there both for influenza and Covid," he said.

Three years after the pandemic

Asked if we were better prepared now three years after the pandemic, Dr Guleria said "We are better prepared than we were in the past because we have learnt a lot from Covid. The challenge of course is that we keep implementing what we have learnt as we move forward and the memory of Covid fades."

Two decades of virus outbreaks

Noting the country has seen a lot of outbreaks in the last 23 years such as swine flu or H1N1, Covid, Nipah virus and monkeypox, he said, "We should learn from what we have seen in the last two decades that we need to prepare. The preparedness has to be in terms of good surveillance, an action plan on how we upscale our health facilities both in terms of human resources and infrastructure."

(Inputs from PTI)